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Colorectal cancer risk is associated with diets high in red meat.
Heme, the pigment of red meat, induces cytotoxicity of colonic
contents and elicits epithelial damage and compensatory hyper-
proliferation leading to hyperplasia. Here we explore the possible
causal role of the gut microbiota in heme-induced hyperprolifera-
tion. To this end, mice were fed a puriﬁed control or heme diet (0.5
μmol/g heme) with or without broad-spectrum antibiotics for 14
days. Heme-induced hyperproliferation was shown to depend on
the presence of the gut microbiota, since hyperproliferation was
completely eliminated by antibiotics, although heme-induced lu-
minal cytotoxicity was sustained in these mice. Colonmucosa tran-
scriptomics revealed that antibiotics block heme-induced differen-
tial expression of oncogenes, tumor-suppressors and cell-turnover
genes, implying that antibiotic treatment prevented the heme-
dependent cytotoxic micelles to reach the epithelium. Our results
indicate that this occurs because antibiotics reinforce the mu-
cus barrier by eliminating sulﬁde-producing bacteria and mucin-
degrading bacteria (e.g. Akkermansia). Sulﬁde potently reduces
disulﬁde bonds and can drive mucin denaturation and microbial
access to the mucus layer. This reduction results in formation of
trisulﬁdes that can be detected in vitro and in vivo. Therefore,
trisulﬁdes can serve as a novel marker of colonic mucolysis and
thus as a proxy for mucus barrier reduction. In feces, antibiotics
drastically decreased trisulﬁdes, but increased mucin polymers
that can be lysed by sulﬁde. We conclude that the gut microbiota
is required for heme-induced epithelial hyperproliferation and
hyperplasia by their capacity to reduce mucus barrier function.
colorectal cancer j red meat j mucus barrier j mucolysis j (tri)sulﬁdes
Introduction
Colorectal cancer, the second leading cause of cancer death in
Western countries, is associated with diets high in red meat (1),
whereas consumption of whitemeat does not have this association
(2). Heme, the iron-porphyrin pigment, is present at much higher
levels in red- compared to white meat. Epidemiological studies
show that heme intake is related to colon cancer risk (3, 4). Our
previous studies show that when rodents consume heme, their
colonic contents become more cytotoxic (5, 6). This increased
cytotoxicity injures the colonic epithelial surface cells. To replace
the injured surface cells, hyperproliferation from the stem cells in
the crypts is initiated. Together with inhibition of apoptosis, this
compensatory hyperproliferation leads to hyperplasia (6), which
eventually can develop into colorectal cancer.
Dietary heme is poorly absorbed in the small intestine; ap-
proximately 90%of dietary heme enters the colon (7). Besides the
toxic effect of heme on the colonic mucosa, dietary heme affects
the microbiota. The relationship between intestinal microbiota
and colon cancer has long been suspected (8). In humans, a red-
meat diet increases Bacteroides spp. in feces (9). We recently
showed that in mice, a heme diet changed the microbiota dras-
tically, majorly increasing the Gram-negative bacteria (mainly
Bacteroidetes, Proteobacteria and Verrucomicrobia) (10). The
gut microbiota can induce hyperproliferation via mechanisms
occurring in the colon lumen, such as modulation of oxidative
and cytotoxic stress or by influencing themucus barrier. Oxidative
stress induces the formation of peroxidized lipids, which react
with heme to form the cytotoxic heme factor (CHF), thereby
increasing cytotoxic stress (5, 11). In a time-course study we
showed that there is a lag time in the formation of CHF and in the
induction of hyperproliferation when mice are transferred from a
control to heme diet (11). This could be due to a time-dependent
adaptation of the microbiota to the heme diet. Notably, heme
does not increase cytotoxicity and epithelial hyperproliferation in
the small intestine (12), indicating that formation of CHF only
occurs in the colon where bacterial density is high. Moreover,
these experiments suggested that CHF-induced hyperprolifera-
tion coincidedwith a reducedmucus barrier function (11), leading
to enhanced contact of colonocytes with microbiota and toxic
substances. In the present study we investigate whether bacteria
play a causal role in heme-induced cytotoxicity and hyperprolif-
eration by using broad-spectrum antibiotics (Abx). Our results
Signiﬁcance
Consumption of red meat is associated with increased colorec-
tal cancer risk. We show that the gut microbiota is pivotal in
this increased risk. Mice receiving a diet with heme, a proxy
for red meat, show a damaged gut epithelium and a com-
pensatory hyperproliferation that can lead to colon cancer.
Mice receiving heme together with antibiotics do not show
this damage and hyperproliferation. Our data indicate that
microbial hydrogen sulﬁde opens the protective mucus barrier
and exposes the epithelium to cytotoxic heme. Antibiotics
block microbial sulﬁde production and thereby maintain the
mucus barrier that prevents heme-induced hyperproliferation.
Our study indicate fecal trisulﬁde as a novel biomarker of
mucus barrier integrity, which could be of relevance in human
colon disease diagnostics.











































































































































Table 1. Effects of heme and Abx on body weight and fecal parameters
Control Heme Control + Abx Heme + Abx
Body weight (g) 27.7 ± 0.5 a 24.9 ± 0.5 b 27.2 ± 0.3 a 24.8 ± 0.4 b
Fecal wet weight (g/day) 0.49 ± 0.08 a 0.60 ± 0.05 a 0.62 ± 0.09 a 1.20 ± 0.19 b
Fecal dry weight (g/day) 0.12 ± 0.01 a 0.11 ± 0.01 a 0.12 ± 0.01 a 0.19 ± 0.02 b
TBARS (MDA equivalents, µmol/L) 12.70 ± 1.43 a 59.84 ± 2.46 b 11.06 ± 1.63 a 46.06 ± 3.92 c
Cytotoxicity (% lysis) 1.09 ± 0.45 a 66.90 ± 10.45 b 0.05 ± 0.04 a 31.30 ± 8.98 c
Mean ± SEM (n=9 per group), differences were tested by ANOVA and Bonferroni post hoc-test. Superscripts indicate signiﬁcant differences (p<0.05).
Fig. 1. A. Counts of total bacteria, Bacteroidetes and Firmicutes measured
by qPCR. Control bars are set at 100%, other bars are relative to controls;
mean ± SEM (n=9/group). B. Bile acid (BA) proﬁles determined by HPLC; mean
± SEM (n=3/group). Letters indicate signiﬁcant different groups (p<0.05),
ANOVA with Bonferroni post-hoc test. (Gly; glycine conjugated, Tau; taurine
conjugated, Sec; secondary
illustrate the crucial role of the gut microbiota in heme-induced
hyperproliferation, and indicate the involvement of microbial
hydrogen sulfide formation in reduction of the polymeric mucin
network to degrade the protective mucus barrier and expose the
colon mucosa to CHF.
Results
Heme- and Abx-induced changes in the colonic lumen.Mice were
divided into 4 groups receiving either a control diet (further re-
ferred to as C-group), a heme diet (H-group), a control diet with
Abx treatment (CA-group), or a heme diet with Abx treatment
(HA-group). After 2 weeks of intervention the H- and HA-group
had a lower body weight as compared to their controls (Table 1).
Fecal dry and wet weight was significantly increased in the HA-
group (Table 1).
To confirm that Abx decreased the abundance of bacteria,
qPCR analyses with specific primers targeting total bacteria,
Bacteroidetes or Firmicutes were performed (Fig. 1A). Abx treat-
ment significantly reduced the abundance of total bacteria and
Firmicutes 100-fold and Bacteroidetes 1,000-fold. Moreover,
the H-group had a significantly increased abundance of Bac-
teroidetes compared to the C-group, which corroborates previous
observations (10). Abx thus drastically decreased the bacterial
density, affecting both the Gram-positive Firmicutes and Gram-
negative Bacteroidetes. To study how this impacts the normal mi-
crobial modification of host compounds, we determined the fecal
bile acid composition. No conjugated bile acids were detected in
fecal water in the C- and H-group, where unconjugated and sec-
ondary bile acids were predominant (Fig. 1B). However, with Abx
almost all bile acids were primary and conjugated with glycine or
taurine (ratio about 3), showing that Abx blocked microbial bile
deconjugation and dehydroxylation almost completely.
Heme increases oxidative and cytotoxic stress in the colon (10,
11). Reactive oxygen species (ROS) induce the formation of lipid
peroxides which react with heme to formCHF, thereby increasing
the cytotoxicity of luminal contents (5, 11). We determined lipid
peroxidation product levels by measuring TBARS in fecal water.
TBARS were low in the C- and CA-group (Table 1) and increased
significantly and to a similar extent in the H- and HA-group,
implying that heme, both in presence and absence ofAbx, induced
ROS-stress. Analogously, fecal water cytotoxicity (Table 1) was
significantly increased in the H- andHA-group compared to their
controls. Since Abx drastically reduced microbiota density (100-
1000 fold), but only slightly reduced cytotoxicity (2-fold) and
TBARS (1.3-fold), it is unlikely that bacteria play a major role
in the formation of TBARS and cytotoxicity.
Heme- and Abx-induced changes in the colonic mucosa.
Morphology analyses of H&E stained colon tissue (Fig. 2A)
confirmed the previously reported heme-induced increased crypt
depth (H- vs C-group). Abx treatment did not affect the colon
morphology in the CA- vs C-group, but completely restored tissue
morphology in the HA- vs H-group. The crypt depth increase
in the H-group did not result from inflammation since neu-
trophil and macrophage infiltration in the lamina propria was
comparable to the C-group. Analogous to earlier reports (6), cell-
proliferation quantification using Ki67-staining (Fig. 2B and 2C)
shows that the heme diet strongly induced cell proliferation (H- vs
C-group), leading to expansion of the proliferative compartment
and increased crypt depth. Abx treatment led to slightly reduced
numbers of cells per crypt in the CA- vs C-group, but did not
significantly affect their labeling index or amount of proliferative
cells. However, Abx treatment in the heme diet (HA- vs H-group)
completely suppressed heme-induced hyperproliferation and hy-
perplasia to levels observed in the C- and CA-groups (Fig. 2C).
In conclusion, heme-induced hyperproliferation and hyperplasia
in mouse colon only occurs in the presence of the gut microbiota.
Abx block the heme-induced expression of cell cycle genes.
Using whole genome transcriptomics we investigated whether
the physiological changes were reflected in gene expression pro-
files. The differentially expressed genes in the H- vs C- and
HA- vs CA-groups are visualized in Fig. S1A. The heme diet
(H- vs C-group) led to 5,507 differentially expressed genes (q-
value<0.01), of which almost 90% (4,859) were not significantly
affected in the HA vs CA comparison. The 4,859 genes specific
for the H-group were analyzed by Gene Set Enrichment Anal-
ysis (GSEA), indicating that mainly cell cycle related processes
were affected by heme (Fig. S1B). Moreover, mining of these
genes for the involved transcription factors (Fig. S1C), revealed
that Cdkn2a, Smarcb1, and the tumor suppressors Tp53 and
Rb1 were inhibited, while oncogenes such as Myc and Foxm1
as well as cell cycle regulators E2f1 and Tbx2, were activated
by heme. Importantly, these processes and transcription factors
were not modulated in the HA-group compared to the CA-
group. There were only 369 differentially expressed genes unique
for the HA-group (Fig. S1A). Notably, none of the modulated
processes identified in the HA-group related to the endpoints
of our study. Because of the specific heme-Abx interaction, the
Abx-mediated differential gene expression profiles and processes
were substantially different in the heme diet background (Table
S1 and S2) as compared to the control diet background (Table S3
and S4). These observations indicate that heme-induced mucosal
gene expression changes of cell cycle related processes require
the presence of the microbiota, which is in agreement with the












































































































































Fig. 2. A. Histochemical H&E staining and B. immunohistochemical Ki67-staining of colon of control and heme-fed mice. C. Quantiﬁcation of Ki67 positive cells
per crypt, total number of cells per crypt and labeling index (percentage of proliferative cells per crypt); mean ± SEM (n=9/group). Letters indicate signiﬁcant
different groups (p<0.05), ANOVA with Bonferroni post-hoc test.
Fig. 3. A. Gene expression of injury markers Birc5, Ier3, Ripk3 and Slpi. B.
immunohistochemical colonic Slpi-staining of control and heme-fed mice. C.
Gene expression of mucin genes 1 to 4 and Galnt 3 and 12. Expression levels
of control is set at 1. Expression of other bars is relative to controls; mean ±
SEM (n=4 for C, H, CA; n=6 for HA). Letters indicate signiﬁcant differences
(p<0.05), ANOVA with Bonferroni post-hoc test.
Abx do not affect the heme-induced antioxidant response.
A set of 648 genes were significantly regulated in both the H-
and HA-group as compared to their controls (Fig. S1A). Of
Fig. 4. A. Bacterial counts of Akkermansia muciniphila and sulfate reducing
bacteria (SRB) determined by qPCR. Controls are set at 100% and other bars
are relative to controls; mean ± SEM (n=8-9/group). Letters indicate signiﬁ-
cant different groups (p<0.05). B. Rate and extent of S-S bond splitting and
synthesis of trisulﬁde bonds; mean ± SD (n=3-6/group),* indicates signiﬁcant
difference with thiol groups (p<0.05). C. Reaction scheme by which sulﬁde
splits S-S bonds. D. Concentrations of sulﬁdes in fecal water; mean ± SEM
(n=8-9/group). E. Excretion of fecal mucins, expressed as µmol O-glycan per
day (n=6-9/group). F. Western blot analysis of fecal mucin with or without
DTT as reducing agent and with sulﬁde. Samples were stained with anti-
Muc2 antibody. Each lane represents a pool of n=9/group. Letters indicate
signiﬁcant different groups (p<0.05), ANOVA with Bonferroni post-hoc test.
those shared genes, 599 were similarly regulated in both groups.
Notably, this group of genes included the activation of several
transcription factors, including the PPARs, involved in fatty acid
metabolism, and Nrf2, involved in antioxidant response (Fig. S1B
and C). This implies that oxidative stress and lipid peroxidation











































































































































Fig. 5. Proposed mechanism of how microbiota facilitates heme-induced
compensatory hyperproliferation. Upper part represents processes when
normal microbiota is present (i.e. without Abx) leading to compensatory
hyperproliferation. Lower part illustrates howAbx cause that themucus layer
is protective against cytotoxic micelles. R-S-S-R indicates native intra- and
intermolecular disulﬁde bonds in the mucus that can be reduced by H2S to
thiols (R-S-H) and trisulﬁdes (R-S-S-S-R). SRB; sulfate-reducing bacteria, CHF;
cytotoxic heme factor.
PPAR target genes in the mucosa, irrespective of the addition of
Abx to the heme diet.
Abx block the mucosal sensing of heme-induced luminal
cytotoxicity. In the colon, the mucus preserves the epithelial
barrier by protecting the surface epithelial cells through creating
a diffusion barrier for toxic micelles (13). In the HA-group,
substantial luminal cytotoxicity was present, but did not induce
hyperproliferation, indicating that CHF did not reach the surface
epithelial cells. We investigated epithelial sensing of cytotoxic-
ity using the marker-genes survivin (Birc5), immediately early
response 3 (Ier3), the necrosis facilitator Ripk3, and secretory
leukocyte protease inhibitor (Slpi), which are upregulated by cell
injury as described earlier (11, 14). In the present study, heme
upregulated the expression of these cytotoxicity sensors only in
the H-group, but not in the HA-group (Fig 3A). In addition, Fig
3B shows that heme only injured surface cells, which corroborates
our laser-capture analysis (6). Taken together, these results indi-
cate that the microbiota is required for the cytotoxic micelles to
reach the surface epithelium, as the diffusion barrier of themucus
layer was maintained by Abx.
An increased mucus barrier could be caused by increased
mucin synthesis, or by decreased mucin degradation. Expression
levels of secretedMuc2 and cell-associatedMuc4 were decreased
in the HA- compared to the H-group (Fig. 3C). Moreover, the
KEGG pathway ‘Mucin type O-Glycan biosynthesis’ was signif-
icantly repressed in the HA- compared to the H-group, accord-
ing to GSEA analysis (q=0.049). For instance, Galnt 3 and 12,
involved in the first step of o-glycosylation, were downregulated
by Abx (Fig. 3C), indicating that mucus layer production is most
probably decreased by Abx. Regarding mucus degradation, it is
well established that the microbiota degrades mucins and uses
their carbohydrates and amino acids as substrates for growth.
In addition, sulfate-reducing bacteria (SRBs) use mucin-derived
sulfate as electron acceptor in anaerobic respiration forming sul-
fides (see also below). As the Abx-treatment drastically reduced
the microbiota density, we hypothesized that Abx increased the
mucus barrier by preventing microbial degradation of mucin.
Notably, the abundance of the mucin-degrading Akkermansia
muciniphila was 8-fold increased by heme, whereas Abx reduced
the abundance of this mucin degrader more than 1000-fold (Fig.
4A). This implies that the relative reduction of the Akkermansia
population by Abx exceeded the overall effect of Abx on the total
microbial load, supporting that Abx treatment could increase
mucus barrier function by strongly reducing the levels of mucin
degraders such as Akkermansia.
Sulfide reduces S-S bonds leading to mucolysis. Mucus is
high in intra- and intermolecular S-S bonds, stabilizing its poly-
meric, network-like structure.When S-S bonds are broken, mucin
monomers dissociate and/or denaturate, leading to decreased
viscosity and higher mucus accessibility for bacterial degradation
(15). SRBs can use mucus-derived sulfate as oxidant in anaero-
bic respiration, generating sulfide. We hypothesized that sulfide
could have a mucolytic effect by reducing the intermolecular S-S
bonds, which contributes to an enhancedmucus barrier in theAbx
groups due to the decreased abundance of SRBs (Fig. 4A) and the
corresponding decrease of luminal sulfide production. We tested
the reducing potency of several sulfur containing compounds on
the model compound DTNB (5,5'-dithiobis-(2-nitrobenzoic acid)
containing a central S-S bond. Splitting of this S-S bond in DTNB
leads to increased absorbance at 412 nm, and the assay allows the
determination of the overall S-S splitting extent as well as the
initial S-S splitting rate (Fig. 4B). Cysteine, glutathione and N-
acetylcysteine (NAC)were able to split the S-S bondwith a similar
rate between 24 to 31 µM/min, whereas the negative control
Na2SO4 did not affect DTNB integrity. Importantly, sulfide gave
a significantly higher rate of S-S bond splitting, 62.4 ± 5.9 µM/min,
indicating that sulfide has a 2-fold more potent mucolytic effect
as compared to the amino-acid thiols that have been shown to
split S-S bonds and make mucins less viscous (16). Moreover,
the overall extent of S-S bond splitting by sulfide was also 2-
fold higher as compared to the other amino-acid thiols. Based on
Ellman's mechanism (17), this indicates that a reactive persulfide
anion originates from the splitting of the first S-S bond, which can
subsequently target a second S-S bond, creating a trisulfide bond.
To quantitate the production of trisulfide bonds, we developed
a method to determine trisulfide bonds based on the difference
between total bound sulfides and acid labile sulfides (18). Indeed,
trisulfide bonds were generated when sulfide was used to reduce
S-S bonds in DTNB (Fig. 4B), but not upon amino-acid thiol
(NAC, GSH or cysteine) treatment of DTNB. The theoretical
(Fig. 4C) as well as the measured ratio (Fig. 4B) of sulfide-
dependent formation of thiol to trisulfide is 2, indicating that all
sulfide reacts with DNTB to form trisulfide bonds.
To test whether similar redox reactions also occurred in vivo,
total sulfides and trisulfides were determined in mice fecal water
(Fig 4D). Heme increased the levels of total bound sulfides, which
is in agreement with literature showing that heme addition to
the growth medium stimulates bacterial reduction of sulfate to
sulfide (19). Concentrations of trisulfide in fecal water ofmice not
receiving Abx were much higher (with H>C) than those of mice
receiving Abx, indicating that Abx suppressed sulfide-dependent
splitting of S-S bonds and thus colonic mucolysis. In line with
this, Abx drastically increased fecal excretion of mucin (Fig. 4E),
because the slightly lower steady-state mucin synthesis (Fig. 3C)
is not anymore balanced by its bacterial degradation. Fecal mucin
was present as a high-molecular-weight form of Muc2 that could
not penetrate the gel in SDS/PAGE analysis (Fig. 4F), whereas
with DTT as a reducing agent most of the Muc2 appeared as a
band of low MW in the gel. To corroborate the reducing effect of
sulfide,Muc2Western blotting was repeated for the CA- andHA-
groups and showed that also sulfide lysed the polymeric Muc2
almost completely (Fig. 4F). Overall, these results indicate that in
normal colon physiology, microbial sulfide opens the polymeric
Muc2 network to bacterial degradation resulting in a lumen-to-
surface permeability gradient through the mucus layer. Abx block
thesemicrobial processes and thereby increase themucus barrier.
Discussion
This study shows that dietary heme changes the microbiota and
increases ROS and cytotoxicity in the colonic lumen. In addition,
heme injures the surface epithelium leading to compensatory











































































































































tumor-suppressor and oncogenes, which increases colorectal can-
cer risk (20, 21). These luminal and epithelial effects of heme are
similar to those detailed in our recent studies (6, 10, 11). The
crucial finding of the present study is that when the microbial
abundance is drastically reduced byAbx, heme does not injure the
surface epithelium and does not induce the carcinogenic changes
in the crypts, mentioned above. This is not due to the slightly
lower levels of cytotoxicity and ROS in the HA-group, which can
be explained by the higher luminal dilution factor because of the
increased fecal wet weight. Recently, we reported that heme diets
induce, in the colon lumen, covalent heme modification resulting
in the very lipophilic and toxic CHF, which is solubilized in mixed
micelles (11). Abx block the mucosal sensing of these cytotoxic
micelles, as they prevent the heme-induced changes in epithelial
histology, and in up regulation of injury markers such as Slpi. In
contrast, Abx do not block mucosal sensing of luminal ROS, as
the Nrf2-mediated antioxidant response was initiated and PPARs
were activated by oxidized lipids in both heme diet groups. This
differential mucosal sensing shows that, with Abx, the mucus
layer is still permeable to small molecules, such as oxidized lipids,
but no longer to larger micellar aggregates containing CHF. The
absence of hyperproliferation in the HA-group also shows that
mucosal exposure toROS does not cause hyperproliferation. This
is in line with our previous observation that ROS is instantly
formed after consumption of the heme diet, while there is a delay
in the appearance of luminal cytotoxicity and the induction of
hyperproliferation (11).
Our study implies that the colon microbiota facilitates heme-
induced epithelial injury and hyperproliferation by opening the
mucus barrier by the concerted action of hydrogen sulfide-
producing and mucin-degrading bacteria. The principal steps of
this hypothesis (Fig. 5) are (i) mucolysis by hydrogen sulfide to
open the compact, protectivemucus layer for (ii) further bacterial
degradation, thereby (iii) allowing diffusion of luminal, cytotoxic,
micelles to the mucosal surface. Consequently, surface epithelial
cells are less protected against luminal cytotoxicity, leading to
induction of compensatory hyperproliferation. The diffusion bar-
rier function of the mucus layer is illustrated by Muc2 KO mice,
which display colitis and epithelial hyperproliferation, as well as
spontaneous development of colorectal cancer (22). In addition,
an in vitro study shows that apically applied mucin creates a dif-
fusion barrier preventing the contact between cytotoxic micelles
and colonocytes (13). That microbiota increase the permeability
of mucus barrier is illustrated by a study of recolonized vs Abx-
treated rats showing that bacteria colonizing the isolated colonic
segment increase epithelial injury by luminally added toxic com-
pounds (23). Unfortunately, there are no established methods to
determine the permeability of the mucus layer in vivo. Although
the mucus layer can be stained in appropriately fixed intestinal
samples, this does not provide information about its permeability,
as its thickness and permeability are not inversely related (15).
Central to our hypothesis is that hydrogen sulfide can re-
duce and thus split S-S bonds, which opens the mucus layer.
The compactness of this layer is determined by disulfide bond-
stabilized polymer Muc2 network of C-terminal dimers and N-
terminal trimers (15). Partial proteolysis by host proteases, which
is visible in our denaturating gels of fecal mucin, does not change
the structure of this network (15). However, splitting of S-S bonds
dissolves it (i.e. mucolysis) resulting in reduced viscosity and in-
creased permeability of themucus layer (15). Typical S-S breaking
agents are N-acetyl-cysteine (NAC), used in the treatment of
cystic fibrosis, L-cysteine and 2-mercaptoethanol, all known to
decrease mucin viscosity, in vivo and in vitro (16). Our DTNB
results show that sulfide, compared with these thiols, is two-fold
more potent in breaking S-S bonds. The pKa of hydrogen sulfide
is about 1 unit lower than that of the thiols, implying that the
concentration of the nucleophilic agent (i.e. the anion) in the
splitting of S-S is higher with hydrogen sulfide. Moreover, as
sulfide donates 2 electrons it splits 2 S-S bonds, whereas thiols
only split one. Elaborating onEllman’smechanism of S-S splitting
(17), we reasoned that the highly nucleophlic persulfide (30),
formed in de first reaction, generates a trisulfide bond in the
second one. Our in vitro results show that trisulfide formation
is indeed specific for S-S reduction by sulfide. Our fecal analysis
shows that trisulfide is also formed in vivo and stimulated by di-
etary heme, probably because bacterial sulfate reduction is heme
dependent (19). Abx strongly reduce overall bacterial abundance
and suppress this trisulfide formation almost completely, support-
ing ourmechanism that trisulfide is formed by bacterial sulfide. In
line with this, Abx greatly increased fecal excretion of Muc2 in a
high MW polymeric form, as shown by nonreducing SDS-PAGE.
Moreover, this polymeric Muc2 dissociates almost completely
after reduction by DTT or sulfide, supporting the hypothesis
that S-S bond splitting by sulfide opens the mucus barrier. This
is supported further by the recent finding that increasing the
number of S-S bonds in the Muc2 network increases the mucus
barrier in mouse colon (24).
Our mechanism of S-S bond splitting by sulfide is supported
by a recent nutritional study by Devkota et al. (25), showing that
mono-association of germ-free mice with the sulfide-producing
proteobacterium Bilophila wardsworthia, in the presence of tau-
rocholate, results in breaking of the mucus barrier. The authors
suggest that this is either due to sulfide (produced from taurine)
or to unconjugated deoxycholate. However, the authors did not
find barrier breaking in the presence of glycocholate, which is
also metabolized to deoxycholate but does not generate sulfide.
Therefore, we feel that their results can only be explained by the
action of taurine-derived sulfide opening the mucus barrier via a
mechanism analogous to what we propose here. Thus, it would be
worthwhile to measure fecal trisulfides in that study.
Also in humans the colonic mucus layer functions as a barrier.
As in mice, it prevents bacterial colonization of the epithelial sur-
face and protects the surface cells from exposure to luminal toxic
compounds (26). Three prevalent microbial profiles, so-called
‘enterotypes’ have been proposed to exist in human microbiota
(27). Interestingly, for two of those enterotypes mucin-degrading
bacteria are identified as microbial drivers. One enterotype is
rich in Prevotella and the co-occurring Desulfovibrio. Prevotella
degrades mucin and Desulfovibrio may enhance the rate limiting
sulfatase step by hydrolyzing glycosyl-sulfate esters. The second
mucin-degrading enterotype is rich in Ruminococcus and Akker-
mansia, both able to degrade mucins. We showed previously that
dietary heme drastically increases the abundance of Prevotella
and Akkermansia (10), which may be of relevance for these two
enterotypes. The third enterotype is rich in Bacteroides using
carbohydrates and proteins as substrates for fermentation (27).
It would be of interest to see whether mucus-barrier differences
between different enterotypes exist or that diseases of the gut,
such as colorectal cancer and IBD, are associated with mucin-
degrading enterotypes. Notably, in some people the colon micro-
biota do not reduce sulfate to hydrogen sulfide (28). Nevertheless,
also in these people our mechanism of mucus barrier breaking
may be of relevance because sulfide can be produced by bacteria
from cysteine (e.g. Prevotella) or from taurine-conjugated bile
acids, see (29) for review. In humans, and in our mice on a
Western diet, the glycine/taurine ratio of bile acid conjugation is
about 3 (30), implying that about 25%of the bile acids spilled over
into the colon contain taurine.
Overall, we conclude that the microbiota facilitates the
heme-induced hyperproliferation by opening the mucus barrier.
Bacterial hydrogen sulfide can reduce the S-S bonds in poly-
meric mucin, thereby increasing the mucus layer permeability
for mucin-degrading bacteria and for cytotoxic micelles. Con-











































































































































heme and compensatory hyperproliferation is initiated. This hy-
perproliferation might eventually lead to colorectal cancer (20).
Our model, as well as our results imply that fecal trisulfides can
serve as a suitable marker of colonic mucolysis. Therefore, it
would be of interest to measure levels of trisulfide in the human
enterotypes, mentioned above, and in gut diseases in which the
mucus barrier is compromised, such as IBD (31).
Materials and methods
Animal handling and design of the study. Experiments were approved by
the Ethical Committee on Animal Testing of Wageningen University and
were in accordance with national law. Eight week-old male C57BL6/J mice
(Harlan, Horst, The Netherlands) were housed individually in a room with
controlled temperature (20-24°C), relative humidity (55%±15%) and a 12h
light dark cycle. Mice were fed diets and demineralized water ad libitum.
Mice (n=9/group) received either a ‘Westernized’ control diet (40 en% fat
(mainly palm-oil), low calcium (30 µmol/g)) or this diet supplemented with
0.5 µmol/g heme for 14 days, as previously described (32). Broad-spectrum
antibiotics (Abx), containing ampicillin (1 g/L), neomycin (1 g/L), and metron-
idazole (0.5 g/L), were administered in drinking water during the time of
intervention. There were 4 experimental groups; control, heme, control plus
Abx and heme plus Abx. Feces were quantitatively collected during days
11-14, frozen at -20°C and subsequently freeze-dried. After 14 days, the
colon was excised, mesenteric fat was removed and the colon was opened
longitudinally, washed in PBS, and cut into three parts. The middle 1.5 cm
colon tissue was formalin-ﬁxed and parafﬁn embedded for histology. The
remaining proximal and distal parts were scraped, pooled per mouse, snap-
frozen in liquid nitrogen and stored at -80°C until further analysis. Colonic
contents were sampled for microbiota analysis. Chemicals were from Sigma-
Aldrich, unless indicated otherwise.
Fecal analyses. Fecal water was prepared by reconstituting freeze-dried
feces with double distilled water to obtain a physiological osmolarity of
300 mOsm/l, as described previously (5). Cytotoxicity of fecal water was
quantiﬁed by potassium release from human erythrocytes after incubation,
as previously described (5) and validated with human colon carcinoma-
derived Caco-2 cells (33). See Supplementary Methods for TBARS, bile acids
and fecal mucin measurements.
Immunohistochemistry. Histological H&E and immunohistochemical
Ki67 (6) and Slpi (34) stainings were performed on parafﬁn embedded colon
sections as described previously. To quantify Ki67-positive colonocytes, 15
crypts per animal were counted. The number of Ki67-positive cells per crypt,
total number of cells per crypt and labeling index were determined.
RNA isolation and microarray analysis. RNA was isolated from colon
scrapings and hybridized on Affymetrix GeneChip Mouse Gene 1.1 ST arrays
(for details see Supplementary Methods). Genes satisfying the criterion
of false discovery rate <1% (q-value<0.01) were considered signiﬁcantly
expressed. Array data were submitted to the Gene Expression Omnibus,
accession number GSE40670.
Bacterial DNA extraction and qPCR. DNA was extracted from approxi-
mately 0.1 g of fresh fecal pellet from the colon using the method described
by Salonen et al (35). By qPCR total bacteria were quantiﬁed using generic
16S rRNA primers and Bacteroidetes and Firmicutes using phylum-speciﬁc 16S
rRNA primers. See supplementary Methods for details.
Reduction of disulﬁde (S-S) bonds. S-S splitting potency of sodium
sulﬁde (Na2S) and thiols was determined using DTNB as model disulﬁde
compound.Western blot analysis of fecal mucinwas performed to determine
whether DTT or sulﬁde reduces disulﬁde bonds in Muc2. See supplementary
Methods for details.
Measurement of trisulﬁde bonds. By GC-MS total bound sulﬁdes and
acid-labile sulﬁdes were measured in each individual fecal water. Trisulﬁdes
were calculated as the difference between those two. See supplementary
Methods for details.
Statistics. In vivo data are presented as mean ± SEM. Differences be-
tween groups were tested for main effects by two-way ANOVA. In vitro data
are given as mean ± SD and differences between groups were tested by one-
wayANOVAwith Bonferroni’sMultiple Comparison Test. P-values <0.05were
considered signiﬁcant.
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